Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel B Jamieson

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Journal of Surgical Case Reports|May 15, 2016
A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resectionSalman A A Jabbar, Nigel B Jamieson, Andrew J Morris, et al.
Journal of the American College of Surgeons|January 17, 2015
Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasmsAjay V Maker, Silvia Carrara, Nigel B Jamieson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomyLavanniya K Palani Velu, Vishnu V Chandrabalan, Salman Jabbar, et al.
Scientific Reports|May 19, 2023
The relationship between heart rate variability and TNM stage, co-morbidity, systemic inflammation and survival in patients with primary operable colorectal cancerJosh McGovern, Stephen Leadbitter, Gillian Miller, et al.
Annals of Surgery|May 21, 2010
Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinomaNigel B Jamieson, Alan K Foulis, Karin A Oien, et al.
Journal of the National Cancer Institute|August 8, 2015
RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III TrialLavanniya K Palani Velu, Colin W Steele, Euan J Dickson, et al.
Annals of Surgical Oncology|May 5, 2012
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinomaNigel B Jamieson, Mohamed Mohamed, Karin A Oien, et al.
Histology and Histopathology|September 8, 2023
Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assaySuad Ak Shamis, Francesca Savioli, Aula Ammar, et al.
Plos One|June 30, 2015
SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer PatientsLiane M McGlynn, Simon McCluney, Nigel B Jamieson, et al.
Annals of Surgical Oncology|January 27, 2011
A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinomaNigel B Jamieson, Simon M Denley, Jennifer Logue, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Journal of Surgical Case Reports|May 15, 2016
A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resectionSalman A A Jabbar, Nigel B Jamieson, Andrew J Morris, et al.
Journal of the American College of Surgeons|January 17, 2015
Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasmsAjay V Maker, Silvia Carrara, Nigel B Jamieson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomyLavanniya K Palani Velu, Vishnu V Chandrabalan, Salman Jabbar, et al.
Scientific Reports|May 19, 2023
The relationship between heart rate variability and TNM stage, co-morbidity, systemic inflammation and survival in patients with primary operable colorectal cancerJosh McGovern, Stephen Leadbitter, Gillian Miller, et al.
Annals of Surgery|May 21, 2010
Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinomaNigel B Jamieson, Alan K Foulis, Karin A Oien, et al.
Journal of the National Cancer Institute|August 8, 2015
RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III TrialLavanniya K Palani Velu, Colin W Steele, Euan J Dickson, et al.
Annals of Surgical Oncology|May 5, 2012
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinomaNigel B Jamieson, Mohamed Mohamed, Karin A Oien, et al.
Histology and Histopathology|September 8, 2023
Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assaySuad Ak Shamis, Francesca Savioli, Aula Ammar, et al.
Plos One|June 30, 2015
SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer PatientsLiane M McGlynn, Simon McCluney, Nigel B Jamieson, et al.
Annals of Surgical Oncology|January 27, 2011
A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinomaNigel B Jamieson, Simon M Denley, Jennifer Logue, et al.
Pageof 11